Evidence map›Paper›PMID 39738976›Full record

ArticleJournal of materials science. Materials in medicine2024

True-bone-ceramics / type I collagen scaffolds for repairing osteochondral defect.

Yuhan Jiang, Tenghai Li, Yingyue Lou, Bingzhang Liu, Yilin Liu, Tian Li, Duo Zhang

Abstract read
In one paragraph

Article in Journal of materials science. Materials in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Research Progress of Bone Grafting: A Comprehensive Review.International journal of nanomedicine · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuhan Jiang *Department of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Changchun, 130021, China.
Tenghai Li *Department of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Changchun, 130021, China.
Yingyue LouDepartment of Rehabilitation, The Second Hospital of Jilin University, Changchun, 130022, China.
Bingzhang LiuDepartment of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Changchun, 130021, China.
Yilin LiuDepartment of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Changchun, 130021, China.
Tian LiDepartment of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Changchun, 130021, China. litian@jlu.edu.cn.
Duo ZhangDepartment of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Changchun, 130021, China. zhangduo@jlu.edu.cn.ORCID http://orcid.org/0000-0002-7372-6799

Funding

Chinese Academy of Medical Sciences CAMS-2017-I2M-1-007First Hospital of Jilin University 0404694001Jilin Provincial Scientific and Technological Development Program YDZJ202301ZYTS443
6 · The paper itself

Abstract

In recent years, the incidence of cartilage defects has increased dramatically, and its etiology is complex and varied. Osteochondritis dissecans (OCD), as one of the main etiologies, damages both cartilage and bone tissues and can progress to severe osteoarthritis, which has been one of the difficult problems for clinicians. The vigorous development of material science and tissue engineering provides new ideas for the treatment of OCD, in which the selection of scaffold materials is particularly important. In this study, true-bone-ceramics (TBC), which has good mechanical strength and osteoconductivity, and type I collagen (COL1), which has excellent biocompatibility, were chosen as scaffold materials to co-construct the TBC/COL1 scaffold for osteochondral repair. In order to ensure the most appropriate collagen coating concentration, three experimental groups (1, 5, 12 mg/ml) were set up. Through the physicochemical property test, biocompatibility analysis and in vivo implantation experiments of composite scaffolds, 12 mg/ml TBC/COL1 scaffolds present the best repair effect among the three groups.

Indexed as

Biocompatible MaterialsCeramicsCollagen Type IMaterials TestingTissue EngineeringTissue ScaffoldsAnimalsBone and BonesHumansMaleRabbitsBiocompatible MaterialsCollagen Type I

Identifiers

PMID39738976
PMCPMC11685269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.